BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Deals

  MRI Diagnostics Maker T2 Biosystems Boosts IPO Cap To $78.2 Million

  July 31, 2014

   · 

  1 min read
• Novartis AG Apologizes For Not Disclosing Side-Effects Of Leukemia Drugs Sooner

  July 31, 2014

   · 

  1 min read
• Deals

  3D Systems Snags Simbionix For $120 Million Cash

  July 31, 2014

   · 

  6 min read
• Policy

  Benefit Of Baxter International, Inc.'s Immune Therapy Outweighs Risk: FDA Panel

  July 31, 2014

   · 

  5 min read
• Business

  Flailing Dendreon Corporation Brings In Ex-Johnson & Johnson Exec For Top CEO Post

  July 31, 2014

   · 

  4 min read
• Deals

  Catalent Pharma Solutions Prices IPO At Midpoint Range, Raises $871 Million

  July 31, 2014

   · 

  2 min read
• Drug Development

  AstraZeneca PLC Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company, Merck & Co., Inc., And Roche

  July 31, 2014

   · 

  1 min read
• Business

  BioLife Solutions, Inc. To Report Financial Results For Second Quarter 2014 And Provide Business Update On August 7, 2014

  July 31, 2014

   · 

  1 min read
• Business

  ChromaDex, Inc. Signs Material Transfer Agreement With Prominent Australian Research Institute For NIAGEN™ Research

  July 31, 2014

   · 

  7 min read
• Biotech Bay

  Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement

  July 31, 2014

   · 

  4 min read